Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Stern

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|December 7, 2019
Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinomaAnna Maria Tsakiroglou, Martin Fergie, Ken Oguejiofor, et al.
Biochimica Et Biophysica Acta|July 9, 2004
Vaccine and antibody-directed T cell tumour immunotherapySaid Dermime, David E Gilham, David M Shaw, et al.
The Journal of General Virology|July 18, 2003
Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasiaEmma J Davidson, Peter Sehr, Rebecca L Faulkner, et al.
Vaccine|December 20, 2008
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunityBalasubramanyam Karanam, Ratish Gambhira, Shiwen Peng, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)Eyad Elkord, Adam Dangoor, Deborah J Burt, et al.
Vaccine|December 4, 2012
Therapy of human papillomavirus-related diseasePeter L Stern, Sjoerd H van der Burg, Ian N Hampson, et al.
The Biochemical Journal|March 21, 2002
Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigenDavid M Shaw, Andrew M Woods, Kevin A Myers, et al.
Journal of the National Cancer Institute|February 19, 2004
TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasiaRenske D M Steenbergen, Debbie Kramer, Boudewijn J M Braakhuis, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 2011
Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapyFernanda V Castro, Mariam Al-Muftah, Kate Mulryan, et al.
Plos One|July 8, 2014
Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV PseudovirionsJoshua W Wang, Subhashini Jagu, Chenguang Wang, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|December 7, 2019
Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinomaAnna Maria Tsakiroglou, Martin Fergie, Ken Oguejiofor, et al.
Biochimica Et Biophysica Acta|July 9, 2004
Vaccine and antibody-directed T cell tumour immunotherapySaid Dermime, David E Gilham, David M Shaw, et al.
The Journal of General Virology|July 18, 2003
Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasiaEmma J Davidson, Peter Sehr, Rebecca L Faulkner, et al.
Vaccine|December 20, 2008
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunityBalasubramanyam Karanam, Ratish Gambhira, Shiwen Peng, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)Eyad Elkord, Adam Dangoor, Deborah J Burt, et al.
Vaccine|December 4, 2012
Therapy of human papillomavirus-related diseasePeter L Stern, Sjoerd H van der Burg, Ian N Hampson, et al.
The Biochemical Journal|March 21, 2002
Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigenDavid M Shaw, Andrew M Woods, Kevin A Myers, et al.
Journal of the National Cancer Institute|February 19, 2004
TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasiaRenske D M Steenbergen, Debbie Kramer, Boudewijn J M Braakhuis, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 2011
Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapyFernanda V Castro, Mariam Al-Muftah, Kate Mulryan, et al.
Plos One|July 8, 2014
Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV PseudovirionsJoshua W Wang, Subhashini Jagu, Chenguang Wang, et al.
Pageof 9